|
Xbrane Biopharma AB (publ) yana da matsayi na #40 a cikin sanarwa Girma a cikin farashin kamfanin na tsawon shekaru 3 a Sweden. Xbrane Biopharma AB (publ) yana da matsayi na #41 a cikin sanarwa Girma daga farashin kuɗin kamfanin na watan a Sweden. Xbrane Biopharma AB (publ) yana da matsayi na #128 a cikin sanarwa Karuwar farashin kamfanin na mako a Sweden. Xbrane Biopharma AB (publ) yana da matsayi na #136 a cikin sanarwa Girma daga farashin kamfanin na watanni 3 a Sweden. Xbrane Biopharma AB (publ) yana da matsayi na #152 a cikin sanarwa Girma a Sweden. Xbrane Biopharma AB (publ) yana da matsayi na #168 a cikin sanarwa Girma daga farashin kamfanin na shekara a Sweden. Xbrane Biopharma AB (publ) yana da matsayi na #40 a cikin sanarwa Girma a cikin farashin kamfanin na tsawon shekaru 3 a kan STO. Xbrane Biopharma AB (publ) yana da matsayi na #41 a cikin sanarwa Girma daga farashin kuɗin kamfanin na watan a kan STO. Xbrane Biopharma AB (publ) yana da matsayi na #128 a cikin sanarwa Karuwar farashin kamfanin na mako a kan STO. Xbrane Biopharma AB (publ) yana da matsayi na #136 a cikin sanarwa Girma daga farashin kamfanin na watanni 3 a kan STO. Xbrane Biopharma AB (publ) yana da matsayi na #152 a cikin sanarwa Girma a kan STO. Xbrane Biopharma AB (publ) yana da matsayi na #168 a cikin sanarwa Girma daga farashin kamfanin na shekara a kan STO.
An daidaita darajar musayar hannun jari akan ta hanyar musayar kanta ne akan layi.Rating Xbrane Biopharma AB (publ) capitalization kamfanin yana kimantawa ne bisa jimlar darajar duk hannun jarin kamfanin. Yawancin hannun jari da kamfanin yake da shi kuma ya fi tsada daya rabon shi, mafi girman darajar. Babu shakka, kamfanoni mafi tsada a duniya sun mamaye babbar darajar ta hanyar kwalliyar mallaka.
Xbrane Biopharma AB (publ) ana samun kudaden shiga ta kashi ɗaya a cikin kowane lokacin kuɗi. Samun kuɗi da rabon - mai nuna alama ta hanyar dabara: duk ribar kamfanin don lokacin rahoton ta yawan hannun jari a kamfanin. Earnarfin "albashi da kashi" yana haɓaka wa waɗancan kamfanoni waɗanda, a matsayinka na doka, albashi da rabon gado suma suna girma.
Jimlar kudin shiga kamfanin a cikin wani tsakaitaccen lissafi ya samar da tushen Xbrane Biopharma AB (publ) Kimar kudin shiga. Samun kuɗin kamfanin ko ribar da yake samu na ƙimar kuɗin shiga yanar gizo baya la'akari da jimlar hannun jarin kamfanin da ƙimar su. Babban matsayi na "kudin shiga kamfanin kamfanin" galibi yana shugabancin manyan kamfanoni da kuma riba mai yawa.
|
